-- Preview Email Newsletter
| Science Research in Professional Journals Newsletter for 2025-11-10 ( 17 items ) |
|
Ablation reduces stroke risk for AFib and may remove need for some types of blood thinners (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Ablation reduces stroke risk for AFib and may remove need for some types of blood thinners
*
Research Highlights:
* Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular heart rhythm, according to an international study.
* Researchers said these findings may suggest that ongoing blood-thinning me more PR
Big Data Before Data Science: Series A Seeks Submissions for Special Journal Issue (10)
LONDON, England, Nov. 9 -- The Royal Statistical Society issued the following news:
* * *
Big Data before Data Science: Series A seeks submissions for special journal issue
The editors of the Journal of the Royal Statistical Society, Series A are seeking submissions for an upcoming special edition: 'Big Data before Data Science: legacies from the collection, analysis, and communication of large-scale human data from an era of paper tools'.
This special issue is inspired by the December 2025 more PR
Chance to win cash doubled medication use, yet led to similar blood pressure reductions (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Chance to win cash doubled medication use, yet led to similar blood pressure reductions
*
Research Highlights:
* A study of 400 adults with high blood pressure found that participants were twice as likely to take their blood pressure medication (measured by electronic pill bottles that recorded when bottles were opened) when they could win a daily cash reward compared t more PR
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides (10)
CLEVELAND, Ohio, Nov. 8 [Category: BizHospital] -- The Cleveland Clinic posted the following news release:
* * *
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides
*
Results from a Cleveland Clinic Phase 1, first-in-human clinical trial showed that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 safely reduced LDL ("bad") cholesterol and triglycerides in people with lipid disorders resistant to current medi more PR
Cup of coffee a day may not be harmful for some adults with AFib and could lower episodes (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Cup of coffee a day may not be harmful for some adults with AFib and could lower episodes
*
Research Highlights:
* During the 6 months after treatment to restore a normal heart rhythm, adults with atrial fibrillation (AFib) who were randomly assigned to drink coffee every day were 39% less likely to have a recurrence of AFib compared to participants assigned to not have more PR
Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib
*
Research Highlights:
* Adults with atrial fibrillation and obesity/overweight (but no diabetes) who took the diabetes medication metformin after a rhythm correction procedure were more likely to stay free of AFib episodes for a year.
* Weight loss was not thought to be the main re more PR
Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease
*
Research Highlights:
* Earlier blood transfusion after major surgery - when hemoglobin was below 10 g/dL rather than beow 7 g/dl - did not affect the risk of severe complications, such as death, heart attack, need for a heart procedure, kidney failure or stroke.
* However, t more PR
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides
*
Research Highlights:
* In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by about 55%.
* Cholesterol more PR
For Black adults in food deserts, food delivery & dietary guidance reduced blood pressure (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
For Black adults in food deserts, food delivery & dietary guidance reduced blood pressure
*
Research Highlights:
* A grocery support program based on the low-sodium DASH eating plan that included home-delivered groceries and dietary counseling reduced blood pressure levels in Black adults living in areas where grocery stores were inaccessible or scarce, known as food de more PR
Heart attack risk halved in adults with heart disease taking tailored vitamin D doses (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Heart attack risk halved in adults with heart disease taking tailored vitamin D doses
*
Research Highlights:
* Adults with heart disease prescribed vitamin D in doses tailored to reach blood levels considered optimal for heart health (>40-80 ng/mL) had a reduced risk of heart attack by more than half (52%) compared to those who did not receive monitoring of vitamin D le more PR
Introducing Gut Science - a Fundamental and Discovery Science Companion Journal to Gut (10)
LONDON, England, Nov. 10 -- The British Society of Gastroenterology issued the following news:
* * *
Introducing Gut Science - a fundamental and discovery science companion journal to Gut
We are excited to announce a new journal from BMJ Group and the British Society of Gastroenterology - Gut Science.
The launch of a new scientific journal is an auspicious moment, all the more so when it will sit alongside one of the world's leading specialty journals. For 65 years, Gut has provided cutting- more PR
Investigational daily pill lowered bad cholesterol as much as injectables (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Investigational daily pill lowered bad cholesterol as much as injectables
*
Research Highlights:
* For people who have experienced a heart attack or stroke, or who are at high risk of one and need further cholesterol lowering, a new daily pill may be a more convenient yet similarly effective option to injectable therapies.
* The oral medication, enlicitide, lowered L more PR
Medication still better than procedure for some irregular heartbeat conditions (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Medication still better than procedure for some irregular heartbeat conditions
*
Research Highlights:
* Standard care, which included medication for those eligible, was better than a promising minimally invasive procedure for people with irregular heart rhythms who had high stroke and bleeding risk.
* The procedure seals off a small pouch of heart tissue, where most more PR
New medication reduced high triglyceride levels, improved cholesterol and liver health (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
New medication reduced high triglyceride levels, improved cholesterol and liver health
*
Research Highlights:
* In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three different receptors linked to triglycerides: FGF21, glucagon more PR
One month of clot prevention after a stent was as effective as year-long course for AFib (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
One month of clot prevention after a stent was as effective as year-long course for AFib
*
Research Highlights:
* A one-month course of dual clot-preventing therapy followed by a single clot-prevention medication for the remainder of the standard 12-month regimen in adults with atrial fibrillation (AFib) who received a coronary stent was as effective as one year of cont more PR
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
*
Research Highlights:
* Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor evolocumab reduced the risk of co more PR
With family support, adults in rural China reduced blood pressure by average of 10 mm Hg (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
With family support, adults in rural China reduced blood pressure by average of 10 mm Hg
*
Research Highlights:
* Adults in rural villages in China who participated in the Healthy Family Program, a family-based intervention that involved regular blood pressure monitoring, the use of low-sodium salt substitutes and educational sessions on healthy lifestyle habits, achiev more PR
|
